| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Gilead Sciences Inc(GILD) | 60,000 | $4.2K | 8.27% |
| 2 | Glaxosmithkline PLC | 100,000 | $3.8K | 7.54% |
| 3 | Pfizer Inc(PFE) | 75,000 | $3.2K | 6.37% |
| 4 | Alkermes PLC(ALKS) | 100,000 | $3.1K | 6.09% |
| 5 | Amryt Pharma PLC | 250,000 | $3.0K | 5.97% |
| 6 | Merck & Co Inc(MRK) | 40,000 | $3.0K | 5.93% |
| 7 | Astrazeneca PLC(AZN) | 50,000 | $3.0K | 5.93% |
| 8 | Bristol-Myers Squibb Co(BMY) | 50,000 | $3.0K | 5.84% |
| 9 | Ironwood Pharmaceuticals Inc(IRWD) | 200,000 | $2.6K | 5.16% |
| 10 | Clovis Oncology Inc(CLVSEUR) | 500,000 | $2.2K | 4.40% |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 99.27% | 59.66% | -39.61% |
| Unclassified | 0.73% | 40.34% | +39.61% |
Quarter-over-quarter weight changes by market cap
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Unclassified | 0.73% | 40.34% | +39.61% |
| Large Cap | 0.52% | 29.28% | +28.76% |
| Mega Cap | 0.25% | 15.59% | +15.34% |
| Mid Cap | 0.15% | 8% | +7.85% |
| Small Cap | 98.35% | 6.78% | -91.57% |
Quarter-over-quarter position changes